Yasuo Takashima

Kyoto, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Proteomic Profiling Reveals HECTD4-dependent Regulation of Protein Ubiquitination and Signaling Pathways in Prostate Cancer.

Proteomic Profiling Reveals HECTD4-dependent Regulation of Protein Ubiquitination and Signaling Pathways in Prostate Cancer.

Journal: Cancer genomics & proteomics
Published: February 18, 2026

Disulfidptosis-linked Gene Signatures Constituted of Prognostic Prediction Models in Prostate Cancer.

Disulfidptosis-linked Gene Signatures Constituted of Prognostic Prediction Models in Prostate Cancer.

Journal: Cancer diagnosis & prognosis
Published: August 07, 2025

Ubiquitin-proteasome Pathway-linked Gene Signatures as Prognostic Indicators in Prostate Cancer.

Ubiquitin-proteasome Pathway-linked Gene Signatures as Prognostic Indicators in Prostate Cancer.

Journal: Anticancer research
Published: March 03, 2025

Case study observational research: inflammatory cytokines in the bronchial epithelial lining fluid of COVID-19 patients with acute hypoxemic respiratory failure.

Case study observational research: inflammatory cytokines in the bronchial epithelial lining fluid of COVID-19 patients with acute hypoxemic respiratory failure.

Journal: Critical care (London, England)
Published: March 14, 2024

Potential marker subset of blood-circulating cytokines on hematopoietic progenitor-to-Th1 pathway in COVID-19.

Potential marker subset of blood-circulating cytokines on hematopoietic progenitor-to-Th1 pathway in COVID-19.

Journal: Frontiers in medicine
Published: October 11, 2023

Reciprocal expression of the immune response genes CXCR3 and IFI44L as module hubs are associated with patient survivals in primary central nervous system lymphoma.

Reciprocal expression of the immune response genes CXCR3 and IFI44L as module hubs are associated with patient survivals in primary central nervous system lymphoma.

Journal: International journal of clinical oncology
Published: August 31, 2022

Survival prediction based on the gene expression associated with cancer morphology and microenvironment in primary central nervous system lymphoma.

Survival prediction based on the gene expression associated with cancer morphology and microenvironment in primary central nervous system lymphoma.

Journal: PloS one
Published: January 25, 2021

Promising Prognosis Marker Candidates on the Status of Epithelial-Mesenchymal Transition and Glioma Stem Cells in Glioblastoma.

Promising Prognosis Marker Candidates on the Status of Epithelial-Mesenchymal Transition and Glioma Stem Cells in Glioblastoma.

Journal: Cells
Published: September 29, 2019

GSEA-assisted gene signatures valid for combinations of prognostic markers in PCNSL.

GSEA-assisted gene signatures valid for combinations of prognostic markers in PCNSL.

Journal: Scientific reports
Published: July 12, 2019

CD276 and the gene signature composed of GATA3 and LGALS3 enable prognosis prediction of glioblastoma multiforme.

CD276 and the gene signature composed of GATA3 and LGALS3 enable prognosis prediction of glioblastoma multiforme.

Journal: PloS one
Published: February 07, 2019

Differential expression of N-linked oligosaccharides in methotrexate-resistant primary central nervous system lymphoma cells.

Differential expression of N-linked oligosaccharides in methotrexate-resistant primary central nervous system lymphoma cells.

Journal: BMC cancer
Published: January 23, 2019

Differential expression of individual transcript variants of PD-1 and PD-L2 genes on Th-1/Th-2 status is guaranteed for prognosis prediction in PCNSL.

Differential expression of individual transcript variants of PD-1 and PD-L2 genes on Th-1/Th-2 status is guaranteed for prognosis prediction in PCNSL.

Journal: Scientific reports
Published: December 18, 2018
Showing 1-12 of 22

Last Updated: 09/26/2026